Ocuphire Pharma Inc (OCUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OCUP | AMGN | VRTX | GILD | BMY |
| Company | Ocuphire Pharma Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3300 | 311.80 | 476.33 | 87.69 | 52.30 |
| High | 1.3600 | 311.80 | 478.06 | 87.69 | 52.30 |
| Low | 1.0715 | 311.80 | 469.62 | 87.69 | 52.30 |
| Last | 1.1700 | 313.58 | 472.74 | 88.16 | 52.38 |
| Change | -0.1600 | -2.42 | +2.38 | +0.08 | -0.12 |
| % Change | -12.03% | -0.77% | +0.51% | +0.09% | -0.23% |
| Volume | 676,700 | 6,232 | 999,600 | 1,934 | 2,628 |
| 20-Day Average Volume | 119,785 | 1,491,492 | 996,915 | 4,612,652 | 8,109,981 |
| Previous Close | 1.3300 | 316.00 | 476.37 | 88.08 | 52.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2790 | 319.37 | 473.09 | 86.49 | 52.85 |
| 20-Day Raw Stochastic | 30.93% | 0.00% | 44.09% | 64.41% | 31.83% |
| 20-Day Relative Strength | 39.97% | 40.67% | 47.97% | 62.53% | 54.08% |
| Weighted Alpha | -63.88 | +12.44 | +21.82 | +17.14 | +4.79 |
| Today's Opinion | 100% Sell | 8% Buy | 8% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 72% Sell | 8% Buy | 40% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 88% Sell | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.59% since 10/16/24 | -0.98% since 10/23/24 | -0.96% since 10/22/24 | +0.53% since 10/23/24 | -1.43% since 10/23/24 |
| Low | 1.0715 on 10/23/24 | 311.80 on 10/30/24 | 464.78 on 10/23/24 | 86.81 on 10/29/24 | 51.81 on 10/28/24 |
| High | 1.3600 on 10/23/24 | 320.14 on 10/28/24 | 480.41 on 10/25/24 | 89.74 on 10/25/24 | 53.40 on 10/24/24 |
| 1-Month | |||||
| %Chg | -13.97% since 09/23/24 | -3.23% since 09/30/24 | +1.62% since 09/27/24 | +4.59% since 09/30/24 | +1.08% since 09/30/24 |
| Low | 1.0715 on 10/23/24 | 311.80 on 10/30/24 | 447.70 on 10/07/24 | 82.82 on 10/01/24 | 51.31 on 10/15/24 |
| High | 1.4163 on 09/24/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| 3-Month | |||||
| %Chg | -43.20% since 07/23/24 | -6.45% since 07/30/24 | -5.58% since 07/29/24 | +12.35% since 07/30/24 | +6.63% since 07/30/24 |
| Low | 1.0715 on 10/23/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 2.0900 on 07/30/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| 6-Month | |||||
| %Chg | -24.03% since 04/23/24 | +13.82% since 04/30/24 | +18.72% since 04/29/24 | +34.49% since 04/30/24 | +19.03% since 04/30/24 |
| Low | 1.0715 on 10/23/24 | 273.38 on 05/01/24 | 391.70 on 04/30/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 2.1800 on 07/18/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 54.54 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,331 | 169,795,968 | 121,400,848 | 109,658,888 | 106,438,240 |
| Shares Outstanding, K | 25,924 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 19,050,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -9,990,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 1,110,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -7,770,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 0.20 | 0.61 | 0.40 | 0.18 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 08/13/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.05 | 0.00 | 18.89 | 38.42 |